In Conversation

Song Ruilin – Chairman, PhIRDA, China

Song Ruilin – Chairman, PhIRDA, China

After so many years of globalization, it is clear that we are interdependent and interconnected. Cutting off the channels of cooperation would lead to harm on both sides
Niklas Hedberg – Chair of the Executive Board, EUnetHTA

Niklas Hedberg – Chair of the Executive Board, EUnetHTA

We need to engage more, explain the system, and clarify the steps that we are taking
Mohamed Mostafa – CEO, PDC-CRO

Mohamed Mostafa – CEO, PDC-CRO

Our commitment to finding effective treatments for patients across the region remains unwavering
Paula Barriga – VP & GM, Novo Nordisk Portugal

Paula Barriga – VP & GM, Novo Nordisk Portugal

We are committed to finding a balanced approach that considers both the imperative of enabling better health outcomes and the need for ensuring the sustainability of the healthcare system
Ashish Lele – Director, National Chemical Laboratory (NCL), India

Ashish Lele – Director, National Chemical Laboratory (NCL), India

One of the prominent challenges the country is facing is the over-dependency on China for APIs. As a country we want to avoid this dependency and rely on our own manufacturing abilities.
Ayman Cheikh Lahlou – CEO, Cooper Pharma

Ayman Cheikh Lahlou – CEO, Cooper Pharma

Starting from scratch in foreign markets requires dedication and adaptability, but it also presents opportunities for growth and learning.
Hubert Mechin – President, AFCROs

Hubert Mechin – President, AFCROs

Leveraging this resource [the Systeme National des Donnees de Sante (SNDS)], we conduct numerous real-world studies, positioning France among the leaders in real-world evidence generation within Europe  
Lars Bo Nielsen – Director General, Danish Medicines Agency (DKMA)

Lars Bo Nielsen – Director General, Danish Medicines Agency (DKMA)

What does AI really mean? How can we make the equipment safe? The solution will be to start with low hanging fruit where risk is low and with equipment that has a lower risk of hurting the patients
See more

In Case You Missed It

InFigures

The world’s top 10 medical technology companies for 2022 according to Medical Product Outsourcing (MPO). Abbott leads the way, followed by Medtronic, J&J, and Siemens Healthineers. Recent PharmaBoardroom interviews with some of these companies’ leading executives include Hugo F. Villegas, SVP & President, Canada & Latin America at Medtronic, Eman Ali, Regional Vice President for…

The subject of intense industry criticism from the likes of lobby groups, Big Pharma, and biotech alike, the Inflation Reduction Act (IRA) subjects certain drugs to price negotiations directly with industry sponsors in the US for the first time. Ten initial drugs – which accounted for over USD 45 billion in Medicare Part D spending…

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here